BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol. 2006;45:607-616. [PMID: 16901579 DOI: 10.1016/j.jhep.2006.07.003] [Cited by in Crossref: 160] [Cited by in F6Publishing: 133] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Kosack CS, Nick S, Shanks L. Diagnostic accuracy evaluation of the ImmunoFlow HCV rapid immunochromatographic test for the detection of hepatitis C antibodies. Journal of Virological Methods 2014;204:6-10. [DOI: 10.1016/j.jviromet.2014.03.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
2 Burgess ST, Kenyon F, O’looney N, Ross AJ, Kwan MC, Beattie JS, Petrik J, Ghazal P, Campbell CJ. A multiplexed protein microarray for the simultaneous serodiagnosis of human immunodeficiency virus/hepatitis C virus infection and typing of whole blood. Analytical Biochemistry 2008;382:9-15. [DOI: 10.1016/j.ab.2008.07.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
3 Zhang X, Gu Y, Cui M, Stallones L, Xiang H. Needlestick and Sharps Injuries Among Nurses at a Teaching Hospital in China. Workplace Health Saf 2015;63:219-25. [PMID: 26031696 DOI: 10.1177/2165079915580035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
4 Atas M, Karatepe Hashas AS, Demircan S, Sarıguzel FM, Baskan B, Yuvacı I, Pangal E, Celik I, Zararsiz G. The Investigation of HCV RNA in Tear Fluid and Aqueous Humor in Patients with Anti-HCV Antibody Positive Who Underwent Cataract Surgery. Ocul Immunol Inflamm 2016;24:297-301. [PMID: 25495483 DOI: 10.3109/09273948.2014.985386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Zehender G, De Maddalena C, Giambelli C, Milazzo L, Schiavini M, Bruno R, Tanzi E, Galli M. Different evolutionary rates and epidemic growth of hepatitis B virus genotypes A and D. Virology. 2008;380:84-90. [PMID: 18715605 DOI: 10.1016/j.virol.2008.07.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lee QJ, Mak WP, Yeung ST, Wong YC, Wai YL. Blood management protocol for total knee arthroplasty to reduce blood wastage and unnecessary transfusion. J Orthop Surg (Hong Kong) 2015;23:66-70. [PMID: 25920648 DOI: 10.1177/230949901502300116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
7 De P, Roy E, Boivin JF, Cox J, Morissette C. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepat 2008;15:279-92. [PMID: 18208496 DOI: 10.1111/j.1365-2893.2007.00942.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
8 Thursz M, Fontanet A. HCV transmission in industrialized countries and resource-constrained areas. Nat Rev Gastroenterol Hepatol. 2014;11:28-35. [PMID: 24080775 DOI: 10.1038/nrgastro.2013.179] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 7.1] [Reference Citation Analysis]
9 Nassef YE, Shady MM, Galal EM, Hamed MA. Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children. Mem Inst Oswaldo Cruz 2013;108:887-93. [PMID: 24141960 DOI: 10.1590/0074-0276130139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
10 Perrett S, Hams P. Raising public awareness of hepatitis B and C through a testing road show. Br J Nurs 2013;22:1308, 1310-2. [PMID: 24335868 DOI: 10.12968/bjon.2013.22.22.1308] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Elsadek Fakhr A, Pourkarim MR, Maes P, Atta AH, Marei A, Azab M, Van Ranst M. Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt. Hepat Mon 2013;13:e12706. [PMID: 24358038 DOI: 10.5812/hepatmon.12706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
12 Fu Y, Xia W, Wang Y, Tian L, Pybus OG, Lu L, Nelson K. The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models. Transfusion 2010;50:1505-11. [PMID: 20456675 DOI: 10.1111/j.1537-2995.2010.02616.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
13 Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, Lei N, Ding K, Wang L, Yu R. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis. 2011;11:88. [PMID: 21477324 DOI: 10.1186/1471-2334-11-88] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
14 Brook G, Soriano V, Bergin C. European guideline for the management of hepatitis B and C virus infections, 2010. Int J STD AIDS 2010;21:669-78. [DOI: 10.1258/ijsa.2010.010234] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
15 Sahakyan Y, Wong WW, Yi Q, Thein HH, Tomlinson GA, Krahn MD. Long-term morbidity and mortality in a Canadian post-transfusion hepatitis C cohort: Over 15 years of follow-up. J Viral Hepat 2020;27:235-42. [PMID: 31654536 DOI: 10.1111/jvh.13226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012;55 Suppl 1:S10-S15. [PMID: 22715208 DOI: 10.1093/cid/cis361] [Cited by in Crossref: 185] [Cited by in F6Publishing: 182] [Article Influence: 18.5] [Reference Citation Analysis]
17 Patel PR, Thompson ND, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis. 2010;56:371-378. [PMID: 20570422 DOI: 10.1053/j.ajkd.2010.01.025] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
18 Mailliard ME, Capadano ME, Hrnicek MJ, Gilroy RK, Gulizia JM. Outcomes of a patient-to-patient outbreak of genotype 3a hepatitis C. Hepatology 2009;50:361-8. [DOI: 10.1002/hep.22992] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
19 Arrais TC, Van Dooren S, Vandamme AM, Brechot C, Rimlinger F, Silva AE, Perez RM, Ferraz ML, Thiers V. Change in hepatitis C virus genotype in hemodialysis patients after end-of-treatment response to interferon monotherapy--relapse or re-infection? J Med Virol 2008;80:80-6. [PMID: 18041025 DOI: 10.1002/jmv.21050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
20 Mandoh SS, Ayman K, Elbardakheny A, Raaft H, Ibrahim AA, Alshaikh RA, Mansour FR. A cross sectional study of the risk factors of hepatitis C infection in North Egypt. Virusdisease 2021;32:22-8. [PMID: 33969153 DOI: 10.1007/s13337-020-00639-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Chen X. Commercial plasma donation and individual health in impoverished rural China. Health Econ Rev 2014;4:30. [PMID: 26208930 DOI: 10.1186/s13561-014-0030-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Trickey A, Hiebert L, Perfect C, Thomas C, El Kaim JL, Vickerman P, Schȕtte C, Hecht R. Hepatitis C virus elimination in Indonesia: Epidemiological, cost and cost-effectiveness modelling to advance advocacy and strategic planning. Liver Int 2020;40:286-97. [PMID: 31454466 DOI: 10.1111/liv.14232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
23 Oliveira-Filho AB, Sawada L, Pinto LC, Locks D, Bahia SL, Brasil-Costa I, Lemos JA. HCV infection among cocaine users in the state of Pará, Brazilian Amazon. Arch Virol 2013;158:1555-60. [PMID: 23408127 DOI: 10.1007/s00705-013-1627-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
24 Narciso-Schiavon JL, Schiavon LL, Carvalho-Filho RJ, Cardoso JR, Freire FC, Sampaio JP, Bordin JO, Soares MA, Silva AE, Ferraz ML. Anti-HCV reactive blood donors: clinical and epidemiological factors associated with false-reactive results. Eur J Gastroenterol Hepatol 2008;20:1071-6. [PMID: 19047838 DOI: 10.1097/MEG.0b013e328303e1d6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Winston A, Wurcel AG, Gordon C, Goyal N. Viral hepatitis in patients on hemodialysis. Semin Dial 2020;33:254-62. [PMID: 32394502 DOI: 10.1111/sdi.12882] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Steinmann E, Gravemann U, Friesland M, Doerrbecker J, Müller TH, Pietschmann T, Seltsam A. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products. Transfusion 2013;53:1010-8. [PMID: 22905868 DOI: 10.1111/j.1537-2995.2012.03858.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
27 Liu F, Chen K, He Z, Ning T, Pan Y, Cai H, Ke Y. Hepatitis C seroprevalence and associated risk factors, Anyang, China. Emerg Infect Dis. 2009;15:1819-1822. [PMID: 19891874 DOI: 10.3201/eid1511.090263] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
28 Mamun-Al-Mahtab, Karim F, Foster G, Akbar SF, Rahman S. Prevalence and risk factors of asymptomatic hepatitis C virus infection in bangladesh. J Clin Exp Hepatol 2011;1:13-6. [PMID: 25755305 DOI: 10.1016/S0973-6883(11)60111-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
29 Butaru AE, Gheonea DI, Rogoveanu I, Diculescu M, Boicea AR, Bunescu M, Streba CT, Oancea CN. Micro-Elimination: Updated Pathway to Global Elimination of Hepatitis C in Small Communities and Industrial Settings during the COVID 19 Pandemic. J Clin Med 2021;10:4976. [PMID: 34768496 DOI: 10.3390/jcm10214976] [Reference Citation Analysis]
30 Omata M, Kanda T, Yu M, Yokosuka O, Lim S, Jafri W, Tateishi R, Hamid SS, Chuang W, Chutaputti A, Wei L, Sollano J, Sarin SK, Kao J, Mccaughan GW. APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatol Int 2012;6:409-35. [DOI: 10.1007/s12072-012-9342-y] [Cited by in Crossref: 114] [Cited by in F6Publishing: 128] [Article Influence: 11.4] [Reference Citation Analysis]
31 Schwarzkopf R, Novikov D, Anoushiravani AA, Feng JE, Vigdorchik J, Schurko B, Dwyer MK, Bedair HS. The preoperative management of Hepatitis C may improve the outcome after total knee arthroplasty. Bone Joint J 2019;101-B:667-74. [PMID: 31154838 DOI: 10.1302/0301-620X.101B6.BJJ-2018-0723.R3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Wu S, Wu F, Hong R, He J. Incidence analyses and space-time cluster detection of hepatitis C in Fujian Province of China from 2006 to 2010. PLoS One 2012;7:e40872. [PMID: 22829893 DOI: 10.1371/journal.pone.0040872] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
33 Matos MA, Reis NRS, Kozlowski AG, Teles SA, Motta-castro ARC, Mello FC, Gomes SA, Martins RM. Epidemiological study of hepatitis A, B and C in the largest Afro-Brazilian isolated community. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009;103:899-905. [DOI: 10.1016/j.trstmh.2009.01.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
34 . Introduction. Kidney International 2008;73:S6-9. [DOI: 10.1038/ki.2008.83] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Forbi JC, Campo DS, Purdy MA, Dimitrova ZE, Skums P, Xia GL, Punkova LT, Ganova-Raeva LM, Vaughan G, Ben-Ayed Y, Switzer WM, Khudyakov YE. Intra-host diversity and evolution of hepatitis C virus endemic to Côte d'Ivoire. J Med Virol 2014;86:765-71. [PMID: 24519518 DOI: 10.1002/jmv.23897] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
36 Sam SS, Steinmetz HB, Tsongalis GJ, Tafe LJ, Lefferts JA. Validation of a solid-phase electrochemical array for genotyping hepatitis C virus. Exp Mol Pathol. 2013;95:18-22. [PMID: 23583628 DOI: 10.1016/j.yexmp.2013.04.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
37 Joseph AM. Treatment of rheumatoid arthritis in patients with concomitant chronic hepatitis C infection. Ther Adv Musculoskelet Dis 2012;4:35-40. [PMID: 22870493 DOI: 10.1177/1759720X11424459] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
38 Yeh YT, Nisic M, Yu X, Xia Y, Zheng SY. Point-of-care microdevices for blood plasma analysis in viral infectious diseases. Ann Biomed Eng 2014;42:2333-43. [PMID: 24879614 DOI: 10.1007/s10439-014-1044-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
39 Negash AA, Gale M Jr. Hepatitis regulation by the inflammasome signaling pathway. Immunol Rev. 2015;265:143-155. [PMID: 25879290 DOI: 10.1111/imr.12279] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
40 Maccarini JDL, Nazario CAK, Ferreira JDS, Ceglio WQGW, Serpa RC, Ferreira VLPC, de Lucca Schiavon L, Narciso-schiavon JL. Positive serology for viral hepatitis and donor self-exclusion in Southern Brazil. Rev Soc Bras Med Trop 2013;46:403-10. [DOI: 10.1590/0037-8682-0094-2013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Bertisch B, Giudici F, Negro F, Moradpour D, Müllhaupt B, Moriggia A, Estill J, Keiser O; Swiss Hepatitis C Cohort Study. Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations. PLoS One 2016;11:e0155464. [PMID: 27227332 DOI: 10.1371/journal.pone.0155464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
42 Mahmud S, Chemaitelly H, Al Kanaani Z, Kouyoumjian SP, Abu-Raddad LJ. Hepatitis C Virus Infection in Populations With Liver-Related Diseases in the Middle East and North Africa. Hepatol Commun. 2020;4:577-587. [PMID: 32258952 DOI: 10.1002/hep4.1491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Alqahtani SM, A Alsagaby S, Mir SA, Alaidarous M, Bin Dukhyil A, Alshehri B, Banawas S, Alturaiki W, Alharbi NK, Azad TA, Al Abdulmonem W. Seroprevalence of Viral Hepatitis B and C among Blood Donors in the Northern Region of Riyadh Province, Saudi Arabia. Healthcare (Basel) 2021;9:934. [PMID: 34442071 DOI: 10.3390/healthcare9080934] [Reference Citation Analysis]
44 Spada E, Mele A, Mariano A, Zuccaro O, Tosti ME. Risk factors for and incidence of acute hepatitis C after the achievement of blood supply safety in Italy: results from the national surveillance system. J Med Virol. 2013;85:433-440. [PMID: 23280786 DOI: 10.1002/jmv.23485] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
45 González-Candelas F, Guiral S, Carbó R, Valero A, Vanaclocha H, González F, Bracho MA. Patient-to-patient transmission of hepatitis C virus (HCV) during colonoscopy diagnosis. Virol J 2010;7:217. [PMID: 20825635 DOI: 10.1186/1743-422X-7-217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
46 Mazzucco W, Chiara di Maio V, Bronte F, Fabeni L, Pipitone RM, Grimaudo S, Ferraro D, Marotta C, Aragri M, Macaluso M, Vitale F, Di Raimondo F, Ceccherini-Silberstein F, Di Marco V. Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy. J Hosp Infect 2021;115:51-8. [PMID: 34171407 DOI: 10.1016/j.jhin.2021.06.007] [Reference Citation Analysis]
47 Liu F, Chen K, He Z, Ning T, Pan Y, Cai H, Ke Y. Hepatitis C seroprevalence and associated risk factors, Anyang, China. Emerg Infect Dis 2009;15:1819-22. [PMID: 19891874 DOI: 10.3201/eid1511.090263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Wang J, Liu J, Huang Y, Wright DJ, Li J, Zhou Z, He W, Yang T, Yao F, Zhu X, Wen G, Bi X, Tiemuer M, Wen X, Huang M, Cao R, Yun Z, Lü Y, Ma H, Guo N, Yu Q, Ness P, Shan H; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) International Component. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations: Hepatitis C in Chinese Blood Donors. Transfusion 2013;53:2489-97. [DOI: 10.1111/trf.12297] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
49 Amarapurkar D. How can we reduce the burden of Hepatitis C? Saudi J Gastroenterol 2011;17:227-8. [PMID: 21727726 DOI: 10.4103/1319-3767.82572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Van Herck K, Vorsters A, Van Damme P. Prevention of viral hepatitis (B and C) reassessed. Best Practice & Research Clinical Gastroenterology 2008;22:1009-29. [DOI: 10.1016/j.bpg.2008.11.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
51 Zhang S, Zhou Y. Dynamics and application of an epidemiological model for hepatitis <mml:math altimg="si18.gif" display="inline" overflow="scroll" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.elsevier.com/xml/ja/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd"><mml:mi>C</mml:mi></mml:math>. Mathematical and Computer Modelling 2012;56:36-42. [DOI: 10.1016/j.mcm.2011.11.081] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
52 Mizuochi T, Takano T, Yanagi T, Ushijima K, Suzuki M, Miyoshi Y, Ito Y, Inui A, Tajiri H. Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in Japan. J Gastroenterol. 2018;53:419-426. [PMID: 28567493 DOI: 10.1007/s00535-017-1351-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
53 Jiménez-Clavero MÁ. Animal viral diseases and global change: bluetongue and West Nile fever as paradigms. Front Genet 2012;3:105. [PMID: 22707955 DOI: 10.3389/fgene.2012.00105] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
54 Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatol Int. 2016;10:681-701. [PMID: 27229718 DOI: 10.1007/s12072-016-9736-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
55 Ko SY, Choe WH. Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals. Clin Mol Hepatol 2018;24:351-7. [PMID: 29544240 DOI: 10.3350/cmh.2017.0063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Brook G, Bhagani S, Kulasegaram R, Torkington A, Mutimer D, Hodges E, Hesketh L, Farnworth S, Sullivan V, Gore C, Devitt E, Sullivan AK; Clinical Effectiveness Group British Association for Sexual Health and HIV. United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015. Int J STD AIDS 2016;27:501-25. [PMID: 26745988 DOI: 10.1177/0956462415624250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
57 Chen P, Zheng Y, Cai Y, Zou P, Li N, Peng C, Gao H, Liu J, Chen Y, Tong Z, Li L. Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter Study. Can J Gastroenterol Hepatol 2020;2020:8219536. [PMID: 32377514 DOI: 10.1155/2020/8219536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Aghemo A, Valenti L, Viganò M, Masetti C, Rumi MG, Prati D. Should individuals who have been cured of hepatitis C virus and their partners be allowed to donate blood? Lancet Haematol 2021;8:e8-e10. [PMID: 33357486 DOI: 10.1016/S2352-3026(20)30402-6] [Reference Citation Analysis]
59 Zhang B, Wang R, Jiang K, Fang X, Li H, Dang N, Zhang T, Zeng B. Prevalence of positivity to antibodies to hepatitis C virus among volunteer blood donors in China: a meta-analysis. Public Health 2021;199:87-95. [PMID: 34571442 DOI: 10.1016/j.puhe.2021.07.011] [Reference Citation Analysis]
60 Deterding K, Wiegand J, Grüner N, Wedemeyer H. Medical procedures as a risk factor for HCV infection in developed countries: do we neglect a significant problem in medical care? J Hepatol. 2008;48:1019-1020; author reply 1020-1021. [PMID: 18439703 DOI: 10.1016/j.jhep.2008.03.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
61 Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S. The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat. 2013;20 Suppl 2:1-20. [PMID: 23827008 DOI: 10.1111/jvh.12120] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
62 Bösenberg AT. Pediatric anesthesia in developing countries. Curr Opin Anaesthesiol 2007;20:204-10. [PMID: 17479022 DOI: 10.1097/ACO.0b013e3280c60c78] [Cited by in Crossref: 46] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
63 Joy JB, McCloskey RM, Nguyen T, Liang RH, Khudyakov Y, Olmstead A, Krajden M, Ward JW, Harrigan PR, Montaner JSG, Poon AFY. The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study. Lancet Infect Dis 2016;16:698-702. [PMID: 27039040 DOI: 10.1016/S1473-3099(16)00124-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
64 Akhtar S, Rozi S. An autoregressive integrated moving average model for short-term prediction of hepatitis C virus seropositivity among male volunteer blood donors in Karachi, Pakistan. World J Gastroenterol 2009; 15(13): 1607-1612 [PMID: 19340903 DOI: 10.3748/wjg.15.1607] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
65 Jochem K, Leclerc P, Maurais E, Tremblay C, Cox J. Accuracy of physician reporting in routine public health surveillance for hepatitis C virus infection. Public Health Rep 2014;129:64-72. [PMID: 24381361 DOI: 10.1177/003335491412900110] [Reference Citation Analysis]
66 Ciccozzi M, Equestre M, Costantino A, Marascio N, Quirino A, Lo Presti A, Cella E, Bruni R, Liberto MC, Focà A. Hepatitis C virus genotype 4d in Southern Italy: reconstruction of its origin and spread by a phylodynamic analysis. J Med Virol. 2012;84:1613-1619. [PMID: 22930510 DOI: 10.1002/jmv.23384] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
67 Marascio N, Matera G, Quirino A, Giancotti A, Barreca GS, Lamberti AG, Caroleo B, Liberto MC, Focà A. Eleven-year distribution pattern of hepatitis C virus in southern Italy. J Pathog. 2012;2012:631095. [PMID: 22934187 DOI: 10.1155/2012/631095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
68 . Guideline 3: Preventing HCV transmission in hemodialysis units. Kidney International 2008;73:S46-52. [DOI: 10.1038/ki.2008.86] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
69 Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion. 2010;50:433-442. [PMID: 19843290 DOI: 10.1111/j.1537-2995.2009.002402.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 6.2] [Reference Citation Analysis]
70 Scott N, Mohamed Z, Rwegasha J, Mbwambo J, Lemoine M, Hellard M. Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness model. Int J Drug Policy. 2021;88:102634. [PMID: 31882272 DOI: 10.1016/j.drugpo.2019.102634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
71 Perz JF, Thompson ND, Schaefer MK, Patel PR. US outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis. 2010;14:137-51; x. [PMID: 20123446 DOI: 10.1016/j.cld.2009.11.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
72 Valois RC, Maradei-Pereira LM, Crescente JÂ, Oliveira-Filho AB, Lemos JA. HCV infection through perforating and cutting material among candidates for blood donation in Belém, Brazilian Amazon. Rev Inst Med Trop Sao Paulo 2014;56:511-5. [PMID: 25351546 DOI: 10.1590/s0036-46652014000600010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
73 Sonnenberg A, Marciniak JY, McCanna J, Krishnan R, Rassenti L, Kipps TJ, Heller MJ. Dielectrophoretic isolation and detection of cfc-DNA nanoparticulate biomarkers and virus from blood. Electrophoresis 2013;34:1076-84. [PMID: 23436471 DOI: 10.1002/elps.201200444] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
74 Scaggiante R, Chemello L, Rinaldi R, Bartolucci GB, Trevisan A. Acute hepatitis C virus infection in a nurse trainee following a needlestick injury. World J Gastroenterol 2013; 19(4): 581-585 [PMID: 23382640 DOI: 10.3748/wjg.v19.i4.581] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
75 Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon. 2012;12:339-343. [PMID: 22783346 DOI: 10.5812/hepatmon.5969] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
76 Thompson N, Hellinger W, Kay R, Cohen L, Ragan P, Voss R, Bacalis L, Xia G, Keating M, Dickson R, Hughes C, Williams I, Perz J. Healthcare-associated hepatitis C virus transmission among patients in an abdominal organ transplant center. Transplant Infectious Disease 2009;11:324-9. [DOI: 10.1111/j.1399-3062.2009.00406.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
77 Brezzi M, Bertisch B, Roelens M, Moradpour D, Terziroli Beretta-Piccoli B, Semmo N, Müllhaupt B, Semela D, Negro F, Keiser O; Swiss Hepatitis C Cohort Study. Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study. PLoS One 2019;14:e0218706. [PMID: 31233524 DOI: 10.1371/journal.pone.0218706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 North CS, Hong BA, Kerr T. Hepatitis C and substance use: new treatments and novel approaches. Curr Opin Psychiatry 2012;25:206-12. [PMID: 22395769 DOI: 10.1097/YCO.0b013e328351f85a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Oliveira-filho ABD, Pimenta ADSC, Rojas MDFM, Chagas MCM, Crespo DM, Crescente JÂB, Lemos JARD. Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern Brazil. Cad Saúde Pública 2010;26:837-44. [DOI: 10.1590/s0102-311x2010000400025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
80 Gelband H, Chen C, Chen W, Franceschi S, Hall SA, London WT, Mcglynn KA, Wild CP. Liver Cancer. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Disease Control Priorities, Third Edition (Volume 3): Cancer. The World Bank; 2015. pp. 147-64. [DOI: 10.1596/978-1-4648-0349-9_ch8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
81 Heikens E, Hetem DJ, Jousma-Rutjes JPW, Nijhuis W, Boland GJ, Hommes NH, Thang OHD, Schuurman R. Hepatitis C virus transmission in a Dutch haemodialysis unit: detailed outbreak investigation using NS5A gene sequencing. J Hosp Infect 2019;101:333-8. [PMID: 30500385 DOI: 10.1016/j.jhin.2018.11.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Zhao Y, Shen L, Ma J, Gao Z, Han X, Qi S, Li Q. Epidemiology of hepatitis C virus infection and risk factor analysis in the Hebei Province, China. PLoS One 2013;8:e75586. [PMID: 24069430 DOI: 10.1371/journal.pone.0075586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
83 Gupta V, Kumar A, Sharma P, Bansal N, Singla V, Arora A. Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center. J Clin Exp Hepatol 2015;5:134-41. [PMID: 26155041 DOI: 10.1016/j.jceh.2015.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
84 de Bruijne J, Weegink CJ, Jansen PL, Reesink HW. New developments in the antiviral treatment of hepatitis C. Vox Sang. 2009;97:1-12. [PMID: 19392783 DOI: 10.1111/j.1423-0410.2009.01187.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
85 Angelotta C, Mckoy JM, Fisher MJ, Buffie CG, Barfi K, Ramsey G, Frohlich L, Bennett CL. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia: Hepatitis C virus and haemophilia. Vox Sanguinis 2007;93:159-65. [DOI: 10.1111/j.1423-0410.2007.00941.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
86 Giudici F, Bertisch B, Negro F, Stirnimann G, Müllhaupt B, Moradpour D, Cerny A, Keiser O; Swiss Hepatitis C Cohort Study. Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach. J Viral Hepat 2016;23:697-707. [PMID: 27006320 DOI: 10.1111/jvh.12535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
87 . Guideline 2: Treatment of HCV infection in patients with CKD. Kidney International 2008;73:S20-45. [DOI: 10.1038/ki.2008.85] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
88 El Ekiaby M, Moftah F, Goubran H, van Drimmelen H, LaPerche S, Kleinman S, Busch M, Lelie N. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios. Transfusion 2015;55:1186-94. [PMID: 25766141 DOI: 10.1111/trf.13061] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
89 Shankaraiah RC, Gramantieri L, Fornari F, Sabbioni S, Callegari E, Negrini M. Animal Models of Hepatocellular Carcinoma Prevention. Cancers (Basel) 2019;11:E1792. [PMID: 31739536 DOI: 10.3390/cancers11111792] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
90 Alter MJ. Healthcare should not be a vehicle for transmission of hepatitis C virus. Journal of Hepatology 2008;48:2-4. [DOI: 10.1016/j.jhep.2007.10.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
91 Harfouche M, Chemaitelly H, Mahmud S, Chaabna K, Kouyoumjian SP, Al Kanaani Z, Abu-Raddad LJ. Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions. Epidemiol Infect. 2017;145:3243-3263. [PMID: 28988562 DOI: 10.1017/s0950268817002242] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
92 Di Marco V, Capra M, Angelucci E, Borgna-pignatti C, Telfer P, Harmatz P, Kattamis A, Prossamariti L, Filosa A, Rund D, Gamberini MR, Cianciulli P, De Montalembert M, Gagliardotto F, Foster G, Grangè JD, Cassarà F, Iacono A, Cappellini MD, Brittenham GM, Prati D, Pietrangelo A, Craxì A, Maggio A; on behalf of the Italian Society for the Study of Thalassemia and Haemoglobinopathies and Italian Association for the Study of the Liver. Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood 2010;116:2875-83. [DOI: 10.1182/blood-2009-11-248724] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
93 Ross RS, Viazov S, Khudyakov YE, Xia GL, Lin Y, Holzmann H, Sebesta C, Roggendorf M, Janata O. Transmission of hepatitis C virus in an orthopedic hospital ward. J Med Virol 2009;81:249-57. [PMID: 19107970 DOI: 10.1002/jmv.21394] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
94 De Gottardi A, Hilleret M, Gelez P, La Mura V, Guillaud O, Majno P, Hadengue A, Morel P, Zarski J, Fontana M, Moradpour D, Mentha G, Boillot O, Leroy V, Giostra E, Dumortier J. Injection drug use before and after liver transplantation: a retrospective multicenter analysis on incidence and outcome: Injection drug use in liver transplantation. Clinical Transplantation 2010;24:564-71. [DOI: 10.1111/j.1399-0012.2009.01121.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
95 Bello-López JM, Castañeda-García C, Muñoz-Estrada C, Machorro-Peréz AJ. External quality control program in screening for infectious diseases at blood banks in Mexico. Transfus Apher Sci 2018;57:97-101. [PMID: 29452838 DOI: 10.1016/j.transci.2018.01.004] [Reference Citation Analysis]
96 Yang J, Hall K, Nuriddin A, Woolard D. Risk for hepatitis B and C virus transmission in nail salons and barbershops and state regulatory requirements to prevent such transmission in the United States. J Public Health Manag Pract 2014;20:E20-30. [PMID: 25250760 DOI: 10.1097/PHH.0000000000000042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
97 Trickey A, Fraser H, Lim AG, Walker JG, Peacock A, Colledge S, Leung J, Grebely J, Larney S, Martin NK, Degenhardt L, Hickman M, May MT, Vickerman P. Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling study. J Viral Hepat 2019;26:1388-403. [PMID: 31392812 DOI: 10.1111/jvh.13187] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
98 Saleh O, Baiomy AA, El-desouky A, Zaghloul H, El-Arman M, Dahab GM, Abdel-Rahman MS. Hepatitis C virus genotype distribution in Egyptian diabetic patients: a preliminary study. Arab J Gastroenterol 2013;14:14-9. [PMID: 23622804 DOI: 10.1016/j.ajg.2013.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
99 Cozzolongo R, Osella AR, Elba S, Petruzzi J, Buongiorno G, Giannuzzi V, Leone G, Bonfiglio C, Lanzilotta E, Manghisi OG. Epidemiology of HCV infection in the general population: a survey in a southern Italian town. Am J Gastroenterol. 2009;104:2740-2746. [PMID: 19638964 DOI: 10.1038/ajg.2009.428] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 4.2] [Reference Citation Analysis]
100 Nwaohiri A, Schillie S, Bulterys M, Kourtis AP. Hepatitis C virus infection in children: How do we prevent it and how do we treat it? Expert Rev Anti Infect Ther 2018;16:689-94. [PMID: 30091654 DOI: 10.1080/14787210.2018.1509707] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
101 Yang J, Zhang Y, Luo L, Meng R, Yu C. Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis. Int J Environ Res Public Health 2018;15:E170. [PMID: 29361804 DOI: 10.3390/ijerph15010170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
102 Baaten GG, Sonder GJ, Dukers NH, Coutinho RA, Van den Hoek JA. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. J Med Virol 2007;79:1802-10. [PMID: 17935187 DOI: 10.1002/jmv.21009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
103 Palliyaguru DL, Wu F. Global geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwide. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2013;30:534-40. [PMID: 23281740 DOI: 10.1080/19440049.2012.751630] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
104 Kunden RD, Khan JQ, Ghezelbash S, Wilson JA. The Role of the Liver-Specific microRNA, miRNA-122 in the HCV Replication Cycle. Int J Mol Sci. 2020;21. [PMID: 32784807 DOI: 10.3390/ijms21165677] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
105 Trickey A, Fraser H, Lim AG, Peacock A, Colledge S, Walker JG, Leung J, Grebely J, Larney S, Martin NK, Hickman M, Degenhardt L, May MT, Vickerman P. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. Lancet Gastroenterol Hepatol 2019;4:435-44. [PMID: 30981685 DOI: 10.1016/S2468-1253(19)30085-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 23] [Article Influence: 17.3] [Reference Citation Analysis]
106 Oliveira-Filho AB, Aires DWF, Cavalcante NS, Raiol NC, Lisboa BLA, Frade PCR, da Costa LM, Pinheiro LML, Machado LFA, Martins LC, Silva-Oliveira GC, Pinho JRR, Kupek E, Lemos JAR. Hepatitis C Virus among Female Sex Workers: A Cross-Sectional Study Conducted along Rivers and Highways in the Amazon Region. Pathogens 2019;8:E236. [PMID: 31739623 DOI: 10.3390/pathogens8040236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
107 Bortolotti F, Verucchi G, Cammà C, Cabibbo G, Zancan L, Indolfi G, Giacchino R, Marcellini M, Marazzi MG, Barbera C. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology. 2008;134:1900-1907. [PMID: 18439604 DOI: 10.1053/j.gastro.2008.02.082] [Cited by in Crossref: 186] [Cited by in F6Publishing: 155] [Article Influence: 13.3] [Reference Citation Analysis]
108 Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. Journal of Hepatology 2008;48:148-62. [DOI: 10.1016/j.jhep.2007.07.033] [Cited by in Crossref: 303] [Cited by in F6Publishing: 293] [Article Influence: 21.6] [Reference Citation Analysis]
109 Sagnelli E, Santantonio T, Coppola N, Fasano M, Pisaturo M, Sagnelli C. Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment. Infection 2014;42:601-10. [DOI: 10.1007/s15010-014-0608-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
110 Goldwater PN. Iatrogenic blood-borne viral infections in refugee children from war and transition zones. Emerg Infect Dis 2013;19. [PMID: 23739597 DOI: 10.3201/eid1906.120806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
111 Rong X, Lu L, Wang J, Xiong H, Huang J, Chen J, Huang K, Xu R, Wang M, Zhang X. Correlation of viral loads with HCV genotypes: higher levels of virus were revealed among blood donors infected with 6a strains. PLoS One. 2012;7:e52467. [PMID: 23285053 DOI: 10.1371/journal.pone.0052467] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
112 . Guideline 4: Management of HCV-infected patients before and after kidney transplantation. Kidney International 2008;73:S53-68. [DOI: 10.1038/ki.2008.87] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
113 Xu S, Wang Q, Zhang W, Qiu Z, Cui J, Yan W, Ni A. Seroprevalence of the Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses and Treponema pallidum at the Beijing General Hospital from 2010 to 2014: A Cross-Sectional Study. PLoS One 2015;10:e0140854. [PMID: 26502175 DOI: 10.1371/journal.pone.0140854] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
114 Palanisamy N, Danielsson A, Kokkula C, Yin H, Bondeson K, Wesslén L, Duberg A, Lennerstrand J. Implications of baseline polymorphisms for potential resistance to NS3 protease inhibitors in Hepatitis C virus genotypes 1a, 2b and 3a. Antiviral Research 2013;99:12-7. [DOI: 10.1016/j.antiviral.2013.04.018] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
115 Wiegand J, Deterding K, Cornberg M, Wedemeyer H. Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha. J Antimicrob Chemother. 2008;62:860-865. [PMID: 18776191 DOI: 10.1093/jac/dkn346] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
116 Morin T, Pariente A, Lahmek P, Rabaud C, Silvain C, Cadranel JF; Association Nationale des Hépato-gastroentérologues des Hôpitaux généraux (ANGH) Société de Pathologie Infectieuse de Langue Française (SPILF) Fédération des Pôles de Référence et Réseaux Hépatites (FPRRH). Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort. Eur J Gastroenterol Hepatol 2010;22:157-66. [PMID: 19734798 DOI: 10.1097/MEG.0b013e328330a8e8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
117 Nelson KE, Shan H. Confirmatory testing of hepatitis C virus–positive enzyme immunoassay results in limited-resource countries: should it be attempted? Transfusion 2008;48:1239-44. [DOI: 10.1111/j.1537-2995.2008.01696.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
118 Saab S, Park SH, Mizokami M, Omata M, Mangia A, Eggleton E, Zhu Y, Knox SJ, Pang P, Subramanian M, Kowdley K, Afdhal NH. Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or older. Hepatology. 2016;63:1112-1119. [PMID: 26704693 DOI: 10.1002/hep.28425] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 9.2] [Reference Citation Analysis]
119 Bellocchi MC, Aragri M, Carioti L, Fabeni L, Pipitone RM, Brancaccio G, Sorbo MC, Barbaliscia S, Di Maio VC, Bronte F, Grimaudo S, Mazzucco W, Frigeri F, Cantone M, Pinto A, Perno CF, Craxì A, Gaeta GB, Di Marco V, Ceccherini-Silberstein F. NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients. Cells 2019;8:E666. [PMID: 31269695 DOI: 10.3390/cells8070666] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
120 Fu Y, Wang Y, Xia W, Pybus OG, Qin W, Lu L, Nelson K. New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat 2011;18:42-52. [PMID: 20196805 DOI: 10.1111/j.1365-2893.2010.01280.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
121 Oliveira-Filho AB, Santos FJA, Silva FQ, Raiol NC, Costa CCS, Piauiense JNF, Martins LC, Cardoso YMN, Di Miceli JFF, Resque RL, Silva-Oliveira GC, Pinheiro LML, Machado LFA, Pinho JRR, Lemos JAR, Kupek E, Fischer B. Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region. BMC Infect Dis 2019;19:634. [PMID: 31315569 DOI: 10.1186/s12879-019-4270-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
122 Pondé RA. Hidden hazards of HCV transmission. Med Microbiol Immunol 2011;200:7-11. [PMID: 20461405 DOI: 10.1007/s00430-010-0159-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
123 Acero Fernández D, Ferri Iglesias MJ, Buxó Pujolràs M, López Nuñez C, Serra Matamala I, Queralt Molés X, Aldeguer Manté X. Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years. Gastroenterol Hepatol 2018;41:2-11. [PMID: 29150360 DOI: 10.1016/j.gastrohep.2017.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
124 Bose B, McDonald SP, Hawley CM, Brown FG, Badve SV, Wiggins KJ, Bannister KM, Boudville N, Clayton P, Johnson DW. Effect of dialysis modality on survival of hepatitis C-infected ESRF patients. Clin J Am Soc Nephrol. 2011;6:2657-2661. [PMID: 21903989 DOI: 10.2215/cjn.02200311] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Nersesov A, Gusmanov A, Crape B, Junusbekova G, Berkinbayev S, Jumabayeva A, Kaibullayeva J, Madenova S, Novitskaya M, Nazarova M, Gaipov A, Ashimkhanova A, Kadyrzhanuly K, Atageldiyeva K, Vento S, Issanov A. Seroprevalence and risk factors for hepatitis B and hepatitis C in three large regions of Kazakhstan. PLoS One 2021;16:e0261155. [PMID: 34914773 DOI: 10.1371/journal.pone.0261155] [Reference Citation Analysis]
126 Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet 2008;372:321-32. [PMID: 18657711 DOI: 10.1016/S0140-6736(08)61116-2] [Cited by in Crossref: 177] [Cited by in F6Publishing: 67] [Article Influence: 12.6] [Reference Citation Analysis]
127 England K, Thorne C, Harris H, Ramsay M, Newell ML. The impact of mode of acquisition on biological markers of paediatric hepatitis C virus infection. J Viral Hepat 2011;18:533-41. [PMID: 21762285 DOI: 10.1111/j.1365-2893.2011.01128.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
128 Pereira FM, Almeida MDCC, Santos FLN, Carreiro RP, Galvão-Castro B, Grassi MFR. Distribution of Human T-Lymphotropic Virus (HTLV) and Hepatitis C Co-infection in Bahia, Brazil. PLoS One 2020;15:e0223087. [PMID: 32692782 DOI: 10.1371/journal.pone.0223087] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
129 Bensalem A, Selmani K, Hihi N, Bencherifa N, Mostefaoui F, Kerioui C, Pineau P, Debzi N, Berkane S. Eastern region represents a worrying cluster of active hepatitis C in Algeria in 2012. J Med Virol 2016;88:1394-403. [PMID: 26856380 DOI: 10.1002/jmv.24491] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
130 Zhang X, Chen Y, Li Y, Hu J, Zhang C, Li Z, Stallones L, Xiang H. Needlestick and Sharps Injuries Among Nursing Students in Nanjing, China. Workplace Health Saf 2018;66:276-84. [DOI: 10.1177/2165079917732799] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
131 González-Candelas F, Bracho MA, Wróbel B, Moya A. Molecular evolution in court: analysis of a large hepatitis C virus outbreak from an evolving source. BMC Biol. 2013;11:76. [PMID: 23870105 DOI: 10.1186/1741-7007-11-76] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
132 Martínez-Rebollar M, Larrousse M, Calvo M, Muñoz A, González A, Loncà M, Martínez E, Blanco JL, Mallolas J, Laguno M. [Current status of acute hepatitis C]. Enferm Infecc Microbiol Clin 2011;29:210-5. [PMID: 21334112 DOI: 10.1016/j.eimc.2010.12.005] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
133 Martínez-Bauer E, Forns X, Armelles M, Planas R, Solà R, Vergara M, Fàbregas S, Vega R, Salmerón J, Diago M. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. J Hepatol. 2008;48:20-27. [PMID: 17998149 DOI: 10.1016/j.jhep.2007.07.031] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 4.7] [Reference Citation Analysis]
134 Silva FQ, Santos FJA, Andrade AP, Pacheco SDB, Fischer B, Pinho JRR, Lemos JAR, Oliveira-Filho AB. Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon. Arch Virol 2018;163:617-22. [PMID: 29164400 DOI: 10.1007/s00705-017-3656-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
135 Batash S, Khaykis I, Raicht RF, Bini EJ. High prevalence of hepatitis C virus infection among immigrants from the former Soviet Union in the New York City metropolitan area: results of a community-based screening program. Am J Gastroenterol 2008;103:922-7. [PMID: 18397420 DOI: 10.1111/j.1572-0241.2008.01789.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
136 Hussain Y, Shahzad A, Azam S, Munawar N. Hepatitis-C and it's seroconversion in end stage kidney disease patients on maintenance hemodialysis and factors affecting it. Pak J Med Sci 2019;35:66-70. [PMID: 30881398 DOI: 10.12669/pjms.35.1.366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]